Table 2 Characteristics of inflammatory and noninflammatory patients with NSCLC

From: The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer

 

C-reactive protein ⩽10 mg l−1 (n=14)

C-reactive protein >10 mg l−1 (n=36)

 
 

Median <6 mg l−1

Median 58 mg l−1

P-value

Age

61 (44–74)

66 (48–88)

0.119

Sex (M/F)

5/9

19/17

0.278

BMI

23.3 (19.7–31.0)

21.9 (14.8–64.2)

0.287

Albumin (g l−1)

42 (38–47)

40 (28–46)

0.014

White cell count (109 l−1)

8.50 (5.60–18.87)

9.55 (5.10–23.50)

0.305

IL-6 (pg ml−1)

2.9 (2.0–22.2)

18.5 (2.0–103.0)

0.001

SIL-6R (ng ml−1)

23.3 (14.0–30.7)

18.8 (7.8–46.0)

0.216

Sgp130 (ng ml−1)

280 (218–330)

298 (227–448)

0.572

sTNF-RII (ng ml−1)

2.5 (1.5–5.1)

3.2 (1.5–6.8)

0.122

IL-1Ra (pg ml−1)

378 (234–902)

724 (132–2128)

0.016

IL-8 (pg ml−1)

<10.0 (<10.0–90.6)

13.9 (<10.0–118.0)

0.152

  1. Median (range).
Back to article page